In the first half of 2026, pharmaceutical and artificial intelligence companies announced fourteen major deals totaling at least US$23.6 billion in potential value, according to a survey by analyst Oliver Sprague Kelly. The prevailing interpretation was that the pharmaceutical industry is betting heavily on radical innovation . I spent a good part of my twenty-five years in the industry in environments where such agreements are discussed and approved, and those who have lived

Technological innovation is a fundamental factor for a country’s economic development and competitiveness. In Brazil, intellectual...

Health innovation and the remarkable growth of the pharmaceutical sector—with a projected global revenue of USD 1.155 trillion in...